COMPANY PROFILE
| Price and Volume | |
|---|---|
| Recent Price | 4.82 |
| 52 Week High | 5.40 |
| 52 Week Low | 2.22 |
| Avg. Daily Vol. (Mil) | 0.03 |
| Beta (3 year) | 1.00 |
| Share Related Items | |
| Mkt Cap (Mil) | 83.86 |
| Shares Out (Mil) | 17.40 |
| Float (Mil) | 16.48 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.00 |
| Current Ratio | 5.40 |
| LT Debt/ Equity | 0.04 |
| Total Debt / Equity | 0.06 |
| Valuation Ratios | |
| Price Earnings | N.A. |
| Price/Sales | 1.56 |
| Price/Book | 2.94 |
| Price/Cash Flow | -1.67K |
| Per Share Data | |
| Earnings | -0.09 |
| Sales | 3.08 |
| Book Value | 1.64 |
| Cash Flow | 0.00 |
| Business Summary | |
|---|---|
| The Company develops, manufactures and sells minimally-invasive medical devices that are used in the diagnosis of breast cancer. | |
| General Information | |
| 11 Columbia
Suite A Aliso Viejo, CA 92656 |
|
| www.senorx.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 155 | |
| CEO: Lloyd H. Malchow | |
| Short Interest | |
| Current Month (Mil) | 0.01 |
| Previous Month (Mil) | 0.01 |
| Short Interest Ratio (Days) | 0.20 |
| Management Effectiveness | |
| Return on Equity | N.A. |
| Return on Assets | -4.90 |
| Return on Investments | -6.00 |
| Profitability | |
| Gross Margin | 73.50 |
| EBIT Margin | -3.00 |
| Profit Margin | -3.30 |